Akums Drugs and Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
AKUMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Akums Drugs and Pharmaceuticals has informed the exchanges that its trading window will be closed for all designated persons (including their immediate relatives) starting 1st July 2025. The window will remain shut until 48 hours after the company announces its unaudited financial results for the quarter ending 30th June 2025 (Q1 FY26). The exact date of the board meeting to approve these quarterly results will be communicated separately. This is a routine compliance measure under SEBI's insider trading regulations.
This is a standard regulatory announcement and has no direct impact on stock price. However, it signals that the company's Q1 FY26 financial results are expected soon, and insiders are barred from trading until those numbers are publicly disclosed.